23rd August 2019
- 0 comments
PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, is delighted to welcome Tim Rea, an investor at BGF, to its board.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.